BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow Reinvestment Rate
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Reinvestment Rate of 0.83x as of September 2025, reinvesting Rs123.88 Million (capex Rs123.88 Million ) from operating cash flow of Rs149.66 Million. See BALAXI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BALAXI PHARMACEUTICALS LIMITED Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for BALAXI PHARMACEUTICALS LIMITED across 6 annual periods. For the full cash flow conversion analysis, see BALAXI PHARMACEUTICALS LIMITED (BALAXI) cash flow conversion.
Annual Cash Flow Reinvestment Rate for BALAXI PHARMACEUTICALS LIMITED (2013–2024)
Year-by-year capital reinvestment analysis for BALAXI PHARMACEUTICALS LIMITED. See BALAXI free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | Rs26.16 Million | Rs48.66 Million | Rs15.69 Million | ▼ -87.2% |
| 2023 | 4.20x | Rs255.45 Million | Rs60.75 Million | Rs149.80 Million | ▲ +366.7% |
| 2022 | 0.90x | Rs307.61 Million | Rs341.44 Million | Rs273.44 Million | ▼ -100.0% |
| 2021 | 1926.71x | Rs59.73 Million | Rs31.00K | Rs25.56 Million | ▲ +13694722.6% |
| 2015 | 0.01x | Rs29.72K | Rs2.11 Million | Rs29.72K | — |
| 2013 | 0.00x | Rs0.00 | Rs3.25 Million | Rs0.00 | — |